Developer docs
API playgroundTry for free, no card

Search company profiles

BioSolveIT

Full company profile

uuid000c23z

Namestring
BioSolveIT
Legal namestring
BioSolveIT GmbH
Websiteurl
biosolveit.de
Company typeenum
Private
Founded yearint
2001
Descriptiontext

BioSolveIT GmbH is a German cheminformatics software company founded in 2001 and headquartered in Sankt Augustin, Germany, with a US affiliate (BioSolveIT Inc.) and distribution partners in the United Kingdom, India, Japan, and China. The company develops computational drug-discovery software built on a combinatorial chemistry approach that enables the screening of trillion-sized compound collections without brute-force enumeration — a methodology trademarked as Chemical Space Docking® and protected by a stack of proprietary algorithms including FTrees (fuzzy pharmacophore similarity), SpaceLight (fingerprint similarity, developed with University of Hamburg ZBH), SpaceMACS (maximum common substructure search), HYDE (visual scoring), and FlexX (protein-ligand docking).

The product portfolio is organized into flagship GUI platforms — SeeSAR (visual drug-design dashboard, now at version 15 'Apollo'), infiniSee (Chemical Space navigation platform combining Scaffold Hopper, Analog Hunter, and Motif Matcher modes), infiniSee xREAL (access point to Enamine's compound catalog), HPSee (high-performance computing workflow environment), and Chemical Space Docking — plus a suite of command-line components (HYDE, FlexX, FlexS, FastGrow, Conformator, FTrees, SpaceLight, SpaceMACS, CoLibri, FlexLM license server). CoLibri allows large pharma customers to construct their own in-house Chemical Spaces from proprietary building blocks and SMIRKS reactions, embedding BioSolveIT's search algorithms into enterprise workflows. The company's Chemical Space assets, accessed via partnerships with Enamine (~95 billion compounds in REAL Space), eMolecules/Synple (8.3+ trillion products in the merged eXplore Space), Chemspace (Freedom Space, 296B), Ambinter (AMBrosia, 125B), OTAVA (CHEMriya, 55B), WuXi LabNetwork (GalaXi, 26B), and Aurigene (AuriVerse, 4.86B), collectively expose customers to tens of billions of make-on-demand, synthetically accessible compounds with a direct virtual-to-vial ordering workflow.

BioSolveIT monetizes through three streams: commercial software licenses (subscription/annual billing via web shop, quote-based enterprise sales, and FlexLM server licensing), free academic licensing supplemented by the Scientific Challenge program (which provides one-year software access plus research grants), and contract research services. Named enterprise customers include Bayer, Roche, Merck, and BASF, alongside an undisclosed cohort of additional pharmaceutical companies building in-house Chemical Spaces with CoLibri. The company is led by Managing Director Dr. Christian Lemmen, operates with 11–50 employees, is privately held with no disclosed external funding rounds, and has been profitable and self-funded for more than two decades.

Short descriptiontext

BioSolveIT GmbH is a German cheminformatics software company (founded 2001) that builds Chemical Space Docking® and related tools (SeeSAR, infiniSee, FTrees, SpaceLight) to screen trillion-sized combinatorial compound collections for pharmaceutical and academic drug-discovery customers.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
11–50
akta.pro rankint
HeadquartersSankt Augustin, Germany
HQ citystring
Sankt Augustin
HQ countrystring
Germany
HQ regionstring
Europe
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
computational drug discovery, cheminformatics software, molecular docking, virtual screening, chemical space navigation
Industry3 codes
PRIMARYHLAGAJAE
Cheminformatics & Molecular Modeling / CADD
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Life Science Software & Informatics (LIMS/ELN/Bioinformatics)
SECONDARYHLAGAJAO
AI/ML Platforms for Drug Discovery & Experiment Optimization
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Life Science Software & Informatics (LIMS/ELN/Bioinformatics)
SECONDARYHLAGAJAC
Scientific Data Management & Data Platforms (SDMS/Data Lakehouse for R&D)
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Life Science Software & Informatics (LIMS/ELN/Bioinformatics)
NAICS code1 code
  • Research and Development in Biotechnology (except Nanobiotechnology)541714
SIC code1 code
  • Services-Commercial Physical & Biological Research8731
Product category
Computational Drug Discovery Software
GTM motion2 records

Each record includes

Type, Description, Source

Revenue model3 records
1Software Licenses (Perpetual/Subscription)
TypeSubscription Recurring
Description

BioSolveIT sells software licenses for its platforms (SeeSAR, infiniSee, HPSee) and components (HYDE, FlexX, FlexS, FastGrow, Conformator, FTrees, SpaceLight, SpaceMACS, CoLibri). Licenses are available via web shop purchase, quote requests, and individual assistance. Evaluation licenses (2-week free trial) are offered for all products. The company also provides academic/free licensing for qualifying institutions.

biosolveit.de
2Contract Research Services
TypeProfessional Services
Description

BioSolveIT acts as a contract research partner, supporting drug discovery projects through the entire process including Chemical Space Docking, scaffold hopping, and custom Chemical Space setup. Services leverage proprietary tools to screen billion-sized Chemical Spaces.

biosolveit.de
3Compound Ordering (Partner Revenue Share)
TypeTransaction Fee
Description

Through partnerships with compound suppliers (Enamine, eMolecules, Ambinter, OTAVA, Chemspace, WuXi LabNetwork, Synple Chem, Aurigene), screening results from Chemical Spaces can be directly ordered. Compounds are delivered within weeks (typically 6-8 weeks for Aurigene's AuriVerse).

biosolveit.de
Marketing channels8 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels4 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Technology or R&D, Personnel, Marketing or Sales, Operations, Infrastructure
Pricing details3 tiers
1Free Evaluation License (2-week trial)
ModelFreemiumBilling cadencePay-as-you-go
Notes

All BioSolveIT products (SeeSAR, infiniSee, infiniSee xREAL, HPSee, HYDE, FlexX, FlexS, FastGrow, Conformator, FTrees, SpaceLight, SpaceMACS, CoLibri, etc.) are available for a free 2-week evaluation period upon registration and host-ID submission.

biosolveit.de
2Academic Free Licensing
ModelFreemiumBilling cadencePay-as-you-go
Notes

Free licensing available for academic institutions. The Scientific Challenge initiative provides software access for a full year to researchers from academia and independent individuals, with the best proposal receiving an additional research grant.

biosolveit.de
3Commercial Software Licenses
ModelSubscriptionBilling cadenceAnnual
Notes

Commercial licenses available via web shop purchase, quote request, or individual assistance contact. Licensing options include evaluation, quote-based, and individual assistance paths. Multiple products support server licenses via FlexLM license server.

biosolveit.de
GTM typeB2B
B2B
Offering typeSoftware
Software
Core offering1 text field

BioSolveIT develops and licenses cheminformatics and molecular modeling software for computational drug discovery, centered on platforms such as SeeSAR (visual drug design dashboard), infiniSee (Chemical Space navigation platform), infiniSee xREAL (Enamine catalog access), HPSee (high-performance computing workflow environment), and Chemical Space Docking. The company also provides contract research services and command-line components (HYDE, FlexX, FTrees, SpaceLight, SpaceMACS, CoLibri) enabling pharmaceutical and academic researchers to screen billions to trillions of synthetically accessible compounds via combinatorial Chemical Space technology, with results directly orderable through partner compound suppliers.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 4 values shown
  • 39% hit rate in ROCK1 virtual screening study (Nature Communications 2022)
+3 more records
Product overview1 text field

BioSolveIT offers a suite of cheminformatics and molecular modeling software for drug discovery. The product portfolio centers on SeeSAR (visual drug design dashboard), infiniSee (Chemical Space navigation platform), infiniSee xREAL (access to Enamine's compound catalog), HPSee (high-performance computing workflow environment), and Chemical Space Docking (structure-based exploration). These platforms are complemented by command-line components including HYDE (scoring), FlexX (docking), FlexS (superposition), FastGrow (pocket exploration), Conformator (3D ensembling), FTrees (pharmacophore similarity), SpaceLight (fingerprint similarity), SpaceMACS (substructure matching), and CoLibri (Chemical Space creation). BioSolveIT also provides access to multiple combinatorial Chemical Spaces including REAL Space (Enamine), eXplore (eMolecules), AuriVerse (Aurigene), Synple Space, Freedom Space, GalaXi, AMBrosia, and CHEMriya.

Product and service7 records
1SeeSAR
CategoryDrug Design Platform
Description

An intuitive, visual drug design dashboard covering every step of the drug discovery process from virtual screening to fragment-based design, fostering ideation through molecular modeling tasks for pharmaceutical and academic researchers.

2infiniSee
CategoryChemical Space Navigation Platform
Description

Chemical Space navigation platform that retrieves molecules of interest from Chemical Spaces of almost infinite size based on similarity to a query structure, featuring Scaffold Hopper (FTrees), Analog Hunter (SpaceLight), and Motif Matcher (SpaceMACS) modes for pharmaceutical and academic drug discovery researchers.

3infiniSee xREAL
CategoryCompound Catalog Access Platform
Description

Exclusive access point to Enamine's largest compound catalog of drug-like molecules, allowing users to browse through trillions of candidates on their own hardware for pharmaceutical drug discovery research.

4HPSee
CategoryHigh-Performance Computing Workflow
Description

Scalable workflow environment that empowers teams with seamless access to high-performance computing for orchestrating jobs, upscaling possibilities, and optimizing virtual screening workflows.

5Chemical Space Docking
CategoryStructure-Based Drug Discovery Method
Description

Structure-based exploration method for mining billions of compounds from ultra-large Chemical Spaces to discover the best drug candidates with exceptional efficiency, marketed as a registered trademark of BioSolveIT GmbH.

6Contract Research Services
CategoryProfessional Drug Discovery Services
Description

BioSolveIT acts as a contract research partner, supporting drug discovery projects through Chemical Space Docking, scaffold hopping, and custom Chemical Space setup, leveraging proprietary tools to screen billion-sized Chemical Spaces for pharmaceutical clients.

7AuriVerse Chemical Space
CategoryCombinatorial Chemical Space
Description

Chemical Space created in collaboration with Aurigene Pharmaceutical Services containing 4.86 billion accessible, drug-like products built from 18 validated reaction protocols and 151,038 in-stock building blocks, delivering compounds in 6-8 weeks with approximately 60% synthesis success rate.

Scale indicator6 records

Each record includes

Type, Value, Description, Source

Partnership9 partners
1Aurigene Pharmaceutical Services
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2026-06-15
Description

Aurigene and BioSolveIT co-created AuriVerse, a Chemical Space with 4.86 billion precision-engineered, drug-like products built from 18 validated reaction protocols and 151,038 in-stock building blocks. This is BioSolveIT's first Chemical Space partnership with an India-based company, extending coverage into a new region of expert make-on-demand chemistry. AuriVerse delivers compounds in 6-8 weeks with ~60% synthesis success rate.

biosolveit.de
Strategic tierCoreTypeStrategic or Co-development Partner
Description

Enamine collaborates with BioSolveIT to create the REAL Space Chemical Space featuring 95 billion drug-like, make-on-demand compounds (as of 2026-04). The partnership enables researchers to screen the world's largest on-demand Chemical Space and directly order identified compounds from Enamine. REAL Space is one of the most widely used Chemical Spaces in pharmaceutical research.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

eMolecules partnered with BioSolveIT to create the eXplore Space, spanning 8.3+ trillion products (as of June 2026). Following eMolecules' merger with Synple, the combined eXplore/Synple Space represents one of the largest searchable compound collections. eMolecules provides compound ordering and synthesis services for all retrieved results.

Strategic tierCoreTypeChannel Partner/ Reseller/ Distributor
Description

Ambinter provides the AMBrosia Chemical Space containing 125 billion compounds (as of 2025-07). Compounds retrieved from AMBrosia searches can be ordered directly via ambrosia@greenpharma.com.

Strategic tierCoreTypeChannel Partner/ Reseller/ Distributor
Description

OTAVA provides the CHEMriya Chemical Space containing 55 billion compounds (as of 2025-10). The space features diverse heterocyclic scaffolds and novel chemotypes. Compounds can be ordered from OTAVA for delivery.

Strategic tierCoreTypeChannel Partner/ Reseller/ Distributor
Description

Chemspace provides the Freedom Space Chemical Space containing 296 billion compounds (as of 2026-03), available for screening with BioSolveIT tools. Building blocks for the space are available for purchase.

7WuXi LabNetwork
Strategic tierCoreTypeChannel Partner/ Reseller/ Distributor
Description

WuXi LabNetwork provides the GalaXi Chemical Space containing 26 billion compounds (as of 2025-09), featuring spiro scaffolds and sp3-rich entries from in-house chemistry. Compounds are purchasable through WuXi LabNetwork.

biosolveit.de
Strategic tierCoreTypeStrategic or Co-development Partner
Description

Following the eMolecules-Synple merger, Synple Chem provides the Synple Space (merged with eXplore, totalling 8.3 trillion compounds as of June 2026). Synple's automated synthesis approaches and building blocks power the space behind the scenes.

9Zentrum für Bioinformatik (ZBH), Hamburg University
Strategic tierMinorTypeStrategic or Co-development Partner
Description

University of Hamburg's ZBH collaborated with BioSolveIT on algorithm development for SpaceLight (fingerprint-based similarity searching in Chemical Spaces) and SpaceMACS (maximum common substructure searching). Prof. Dr. Matthias Rarey leads the ZBH team.

biosolveit.de
Recent move2 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight6 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

Direct peer providing computational chemistry software (Flare, Spark, Blaze) for ligand-based and structure-based drug design. Overlaps with BioSolveIT in scaffold hopping and 3D molecular modeling.

TypeDirect peer
Description

Direct peer in computational drug discovery software, offering physics-based molecular simulation, FEP+, and LiveDesign. Competes with BioSolveIT for pharma CADD budgets but operates at much greater scale and scope.

TypeEmerging player
Description

Emerging player aggregating compound sourcing from global suppliers. Comparable to BioSolveIT's Chemical Space supplier partnerships in serving the make-on-demand compound procurement workflow adjacent to virtual screening.

TypeDirect peer
Description

Direct peer providing cheminformatics toolkits (JChem, Marvin, Chemicalize) used by pharma for molecule handling, similarity, and structure processing. Comparable to BioSolveIT's command-line components for chemical informatics.

TypeBroad incumbent
Description

Broad incumbent offering BIOVIA Discovery Studio and related pipelines for molecular modeling and drug discovery. Competes with BioSolveIT for enterprise pharma CADD seats but at much larger platform scale.

TypeDirect peer
Description

Direct peer offering StarDrop for compound scoring, ADME prediction, and multi-parameter optimization. Already an integration partner of BioSolveIT via ADME predictions inside infiniSee, illustrating deep functional overlap.

TypeBroad incumbent
Description

Broad incumbent in scientific informatics for drug discovery, offering an end-to-end R&D platform that competes with BioSolveIT for pharma software spend. Larger scale and broader scope than BioSolveIT's CADD-focused portfolio.

TypeEmerging player
Description

Listed partner of BioSolveIT and an AI-driven drug discovery company combining physics-based modeling with ML for hit identification. Adjacent to BioSolveIT's CADD approach but with stronger AI/ML emphasis and greater scale.

TypeDirect peer
Description

Direct peer offering the MOE (Molecular Operating Environment) drug discovery platform, including docking, pharmacophore, and QSAR tools. Comparable to SeeSAR for integrated drug design workflows.

TypeDirect peer
Description

Direct peer providing cheminformatics and molecular modeling tools (OEDocking, ROCS, FRED) widely used in pharma. Targets the same medicinal chemistry and virtual screening use cases as BioSolveIT's SeeSAR and infiniSee.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat5 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers5 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment3 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile3 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

Integration1 record

Each record includes

Title, Type, Description, Source

AI maturity
App detail

Has app

Feature12 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles1 record

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

Subsidiaries1 record

Each record includes

Name, Acquired on, Relationship type, Type, Business focus

No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

BioSolveIT

Computational Drug Discovery Softwarebiosolveit.de

BioSolveIT GmbH is a German cheminformatics software company (founded 2001) that builds Chemical Space Docking® and related tools (SeeSAR, infiniSee, FTrees, SpaceLight) to screen trillion-sized combinatorial compound collections for pharmaceutical and academic drug-discovery customers.

What BioSolveIT does

BioSolveIT GmbH is a German cheminformatics software company founded in 2001 and headquartered in Sankt Augustin, Germany, with a US affiliate (BioSolveIT Inc.) and distribution partners in the United Kingdom, India, Japan, and China. The company develops computational drug-discovery software built on a combinatorial chemistry approach that enables the screening of trillion-sized compound collections without brute-force enumeration — a methodology trademarked as Chemical Space Docking® and protected by a stack of proprietary algorithms including FTrees (fuzzy pharmacophore similarity), SpaceLight (fingerprint similarity, developed with University of Hamburg ZBH), SpaceMACS (maximum common substructure search), HYDE (visual scoring), and FlexX (protein-ligand docking).

The product portfolio is organized into flagship GUI platforms — SeeSAR (visual drug-design dashboard, now at version 15 'Apollo'), infiniSee (Chemical Space navigation platform combining Scaffold Hopper, Analog Hunter, and Motif Matcher modes), infiniSee xREAL (access point to Enamine's compound catalog), HPSee (high-performance computing workflow environment), and Chemical Space Docking — plus a suite of command-line components (HYDE, FlexX, FlexS, FastGrow, Conformator, FTrees, SpaceLight, SpaceMACS, CoLibri, FlexLM license server). CoLibri allows large pharma customers to construct their own in-house Chemical Spaces from proprietary building blocks and SMIRKS reactions, embedding BioSolveIT's search algorithms into enterprise workflows. The company's Chemical Space assets, accessed via partnerships with Enamine (~95 billion compounds in REAL Space), eMolecules/Synple (8.3+ trillion products in the merged eXplore Space), Chemspace (Freedom Space, 296B), Ambinter (AMBrosia, 125B), OTAVA (CHEMriya, 55B), WuXi LabNetwork (GalaXi, 26B), and Aurigene (AuriVerse, 4.86B), collectively expose customers to tens of billions of make-on-demand, synthetically accessible compounds with a direct virtual-to-vial ordering workflow.

BioSolveIT monetizes through three streams: commercial software licenses (subscription/annual billing via web shop, quote-based enterprise sales, and FlexLM server licensing), free academic licensing supplemented by the Scientific Challenge program (which provides one-year software access plus research grants), and contract research services. Named enterprise customers include Bayer, Roche, Merck, and BASF, alongside an undisclosed cohort of additional pharmaceutical companies building in-house Chemical Spaces with CoLibri. The company is led by Managing Director Dr. Christian Lemmen, operates with 11–50 employees, is privately held with no disclosed external funding rounds, and has been profitable and self-funded for more than two decades.

BioSolveIT firmographics

Firmographics
Name
BioSolveIT
Legal name
BioSolveIT GmbH
Website
https://biosolveit.de
Company type
Private
Founded year
2001
Operating status
Operating
Headcount range
11–50 employees
Short description
BioSolveIT GmbH is a German cheminformatics software company (founded 2001) that builds Chemical Space Docking® and related tools (SeeSAR, infiniSee, FTrees, SpaceLight) to screen trillion-sized combinatorial compound collections for pharmaceutical and academic drug-discovery customers.
Ownership category
akta.pro rank

BioSolveIT industry classification

Industry
Product category
Computational Drug Discovery Software
NAICS
Research and Development in Biotechnology (except Nanobiotechnology) (541714)
SIC
Services-Commercial Physical & Biological Research (8731)
akta.pro industry
PRIMARYHLAGAJAE
Cheminformatics & Molecular Modeling / CADD
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Life Science Software & Informatics (LIMS/ELN/Bioinformatics)
SECONDARYHLAGAJAO
AI/ML Platforms for Drug Discovery & Experiment Optimization
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Life Science Software & Informatics (LIMS/ELN/Bioinformatics)
SECONDARYHLAGAJAC
Scientific Data Management & Data Platforms (SDMS/Data Lakehouse for R&D)
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Life Science Software & Informatics (LIMS/ELN/Bioinformatics)

Keywords

  • Computational drug discovery
  • Cheminformatics software
  • Molecular docking
  • Virtual screening
  • Chemical space navigation

Where BioSolveIT is headquartered

Location

Headquarters

HQ city
Sankt Augustin
HQ country
Germany
HQ region
Europe

Offices1 record

Markets served

BioSolveIT business model

Business model
GTM type
B2B
Offering type
Software
Cost components
Technology or R&D, Personnel, Marketing or Sales, Operations, Infrastructure

Revenue model

  1. Software Licenses (Perpetual/Subscription): BioSolveIT sells software licenses for its platforms (SeeSAR, infiniSee, HPSee) and components (HYDE, FlexX, FlexS, FastGrow, Conformator, FTrees, SpaceLight, SpaceMACS, CoLibri). Licenses are available via web shop purchase, quote requests, and individual assistance. Evaluation licenses (2-week free trial) are offered for all products. The company also provides academic/free licensing for qualifying institutions.
  2. Contract Research Services: BioSolveIT acts as a contract research partner, supporting drug discovery projects through the entire process including Chemical Space Docking, scaffold hopping, and custom Chemical Space setup. Services leverage proprietary tools to screen billion-sized Chemical Spaces.
  3. Compound Ordering (Partner Revenue Share): Through partnerships with compound suppliers (Enamine, eMolecules, Ambinter, OTAVA, Chemspace, WuXi LabNetwork, Synple Chem, Aurigene), screening results from Chemical Spaces can be directly ordered. Compounds are delivered within weeks (typically 6-8 weeks for Aurigene's AuriVerse).

Pricing tiers

ModelBillingPrice
FreemiumPay-as-you-goFree Evaluation License (2-week trial)
FreemiumPay-as-you-goAcademic Free Licensing
SubscriptionAnnualCommercial Software Licenses

Go-to-market motion2 records

Distribution channels4 records

Marketing channels8 records

BioSolveIT product offering

Product offering

Core offering

BioSolveIT develops and licenses cheminformatics and molecular modeling software for computational drug discovery, centered on platforms such as SeeSAR (visual drug design dashboard), infiniSee (Chemical Space navigation platform), infiniSee xREAL (Enamine catalog access), HPSee (high-performance computing workflow environment), and Chemical Space Docking. The company also provides contract research services and command-line components (HYDE, FlexX, FTrees, SpaceLight, SpaceMACS, CoLibri) enabling pharmaceutical and academic researchers to screen billions to trillions of synthetically accessible compounds via combinatorial Chemical Space technology, with results directly orderable through partner compound suppliers.

Product overview

BioSolveIT offers a suite of cheminformatics and molecular modeling software for drug discovery. The product portfolio centers on SeeSAR (visual drug design dashboard), infiniSee (Chemical Space navigation platform), infiniSee xREAL (access to Enamine's compound catalog), HPSee (high-performance computing workflow environment), and Chemical Space Docking (structure-based exploration). These platforms are complemented by command-line components including HYDE (scoring), FlexX (docking), FlexS (superposition), FastGrow (pocket exploration), Conformator (3D ensembling), FTrees (pharmacophore similarity), SpaceLight (fingerprint similarity), SpaceMACS (substructure matching), and CoLibri (Chemical Space creation). BioSolveIT also provides access to multiple combinatorial Chemical Spaces including REAL Space (Enamine), eXplore (eMolecules), AuriVerse (Aurigene), Synple Space, Freedom Space, GalaXi, AMBrosia, and CHEMriya.

Differentiator

Problem solved

Functional benefit

Products and services

  • SeeSAR An intuitive, visual drug design dashboard covering every step of the drug discovery process from virtual screening to fragment-based design, fostering ideation through molecular modeling tasks for pharmaceutical and academic researchers.
  • infiniSee Chemical Space navigation platform that retrieves molecules of interest from Chemical Spaces of almost infinite size based on similarity to a query structure, featuring Scaffold Hopper (FTrees), Analog Hunter (SpaceLight), and Motif Matcher (SpaceMACS) modes for pharmaceutical and academic drug discovery researchers.
  • infiniSee xREAL Exclusive access point to Enamine's largest compound catalog of drug-like molecules, allowing users to browse through trillions of candidates on their own hardware for pharmaceutical drug discovery research.
  • HPSee Scalable workflow environment that empowers teams with seamless access to high-performance computing for orchestrating jobs, upscaling possibilities, and optimizing virtual screening workflows.
  • Chemical Space Docking Structure-based exploration method for mining billions of compounds from ultra-large Chemical Spaces to discover the best drug candidates with exceptional efficiency, marketed as a registered trademark of BioSolveIT GmbH.
  • Contract Research Services BioSolveIT acts as a contract research partner, supporting drug discovery projects through Chemical Space Docking, scaffold hopping, and custom Chemical Space setup, leveraging proprietary tools to screen billion-sized Chemical Spaces for pharmaceutical clients.
  • AuriVerse Chemical Space Chemical Space created in collaboration with Aurigene Pharmaceutical Services containing 4.86 billion accessible, drug-like products built from 18 validated reaction protocols and 151,038 in-stock building blocks, delivering compounds in 6-8 weeks with approximately 60% synthesis success rate.

Quantifiable outcome

  • 39% hit rate in ROCK1 virtual screening study (Nature Communications 2022)
  • +3 more outcomes

Companies that use BioSolveIT

Customer profile

Named customers5 records

Segments3 records

Ideal customer profiles3 records

BioSolveIT technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Integration1 record

Feature12 records

BioSolveIT partnerships and signals

Strategic signal

Partnerships

Nine partnerships are on record, tiered core and minor.

  • Aurigene Pharmaceutical ServicescoreStrategic or Co-development Partner · 15 June 2026Aurigene and BioSolveIT co-created AuriVerse, a Chemical Space with 4.86 billion precision-engineered, drug-like products built from 18 validated reaction protocols and 151,038 in-stock building blocks. This is BioSolveIT's first Chemical Space partnership with an India-based company, extending coverage into a new region of expert make-on-demand chemistry. AuriVerse delivers compounds in 6-8 weeks with ~60% synthesis success rate.
  • EnaminecoreStrategic or Co-development PartnerEnamine collaborates with BioSolveIT to create the REAL Space Chemical Space featuring 95 billion drug-like, make-on-demand compounds (as of 2026-04). The partnership enables researchers to screen the world's largest on-demand Chemical Space and directly order identified compounds from Enamine. REAL Space is one of the most widely used Chemical Spaces in pharmaceutical research.
  • eMoleculescoreStrategic or Co-development PartnereMolecules partnered with BioSolveIT to create the eXplore Space, spanning 8.3+ trillion products (as of June 2026). Following eMolecules' merger with Synple, the combined eXplore/Synple Space represents one of the largest searchable compound collections. eMolecules provides compound ordering and synthesis services for all retrieved results.
  • Ambinter (Greenpharma)coreChannel Partner/ Reseller/ DistributorAmbinter provides the AMBrosia Chemical Space containing 125 billion compounds (as of 2025-07). Compounds retrieved from AMBrosia searches can be ordered directly via ambrosia@greenpharma.com.
  • OTAVAchemicalscoreChannel Partner/ Reseller/ DistributorOTAVA provides the CHEMriya Chemical Space containing 55 billion compounds (as of 2025-10). The space features diverse heterocyclic scaffolds and novel chemotypes. Compounds can be ordered from OTAVA for delivery.
  • ChemspacecoreChannel Partner/ Reseller/ DistributorChemspace provides the Freedom Space Chemical Space containing 296 billion compounds (as of 2026-03), available for screening with BioSolveIT tools. Building blocks for the space are available for purchase.
  • WuXi LabNetworkcoreChannel Partner/ Reseller/ DistributorWuXi LabNetwork provides the GalaXi Chemical Space containing 26 billion compounds (as of 2025-09), featuring spiro scaffolds and sp3-rich entries from in-house chemistry. Compounds are purchasable through WuXi LabNetwork.
  • Synple Chem AGcoreStrategic or Co-development PartnerFollowing the eMolecules-Synple merger, Synple Chem provides the Synple Space (merged with eXplore, totalling 8.3 trillion compounds as of June 2026). Synple's automated synthesis approaches and building blocks power the space behind the scenes.
  • Zentrum für Bioinformatik (ZBH), Hamburg UniversityminorStrategic or Co-development PartnerUniversity of Hamburg's ZBH collaborated with BioSolveIT on algorithm development for SpaceLight (fingerprint-based similarity searching in Chemical Spaces) and SpaceMACS (maximum common substructure searching). Prof. Dr. Matthias Rarey leads the ZBH team.

Scale indicators6 records

Recent moves2 records

Expansion highlights6 records

BioSolveIT competitors and assessment

Company assessment

Direct peers

  • Cresset: Direct peer providing computational chemistry software (Flare, Spark, Blaze) for ligand-based and structure-based drug design. Overlaps with BioSolveIT in scaffold hopping and 3D molecular modeling.
  • Schrödinger: Direct peer in computational drug discovery software, offering physics-based molecular simulation, FEP+, and LiveDesign. Competes with BioSolveIT for pharma CADD budgets but operates at much greater scale and scope.
  • ChemAxon: Direct peer providing cheminformatics toolkits (JChem, Marvin, Chemicalize) used by pharma for molecule handling, similarity, and structure processing. Comparable to BioSolveIT's command-line components for chemical informatics.
  • Optibrium: Direct peer offering StarDrop for compound scoring, ADME prediction, and multi-parameter optimization. Already an integration partner of BioSolveIT via ADME predictions inside infiniSee, illustrating deep functional overlap.
  • Chemical Computing Group (CCG): Direct peer offering the MOE (Molecular Operating Environment) drug discovery platform, including docking, pharmacophore, and QSAR tools. Comparable to SeeSAR for integrated drug design workflows.
  • OpenEye Scientific (Cadence Design Systems): Direct peer providing cheminformatics and molecular modeling tools (OEDocking, ROCS, FRED) widely used in pharma. Targets the same medicinal chemistry and virtual screening use cases as BioSolveIT's SeeSAR and infiniSee.

Emerging players

  • MolPort: Emerging player aggregating compound sourcing from global suppliers. Comparable to BioSolveIT's Chemical Space supplier partnerships in serving the make-on-demand compound procurement workflow adjacent to virtual screening.
  • XtalPi: Listed partner of BioSolveIT and an AI-driven drug discovery company combining physics-based modeling with ML for hit identification. Adjacent to BioSolveIT's CADD approach but with stronger AI/ML emphasis and greater scale.

Broad incumbents

  • BIOVIA (Dassault Systèmes): Broad incumbent offering BIOVIA Discovery Studio and related pipelines for molecular modeling and drug discovery. Competes with BioSolveIT for enterprise pharma CADD seats but at much larger platform scale.
  • Dotmatics: Broad incumbent in scientific informatics for drug discovery, offering an end-to-end R&D platform that competes with BioSolveIT for pharma software spend. Larger scale and broader scope than BioSolveIT's CADD-focused portfolio.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

BioSolveIT social profiles

Digital presence

BioSolveIT financial estimates

Financial estimate

Revenue estimate

Valuation estimate

BioSolveIT leadership team

Management profile

Number of profiles

Profiles1 record

BioSolveIT subsidiaries and ownership

Company hierarchy

Subsidiaries1 record

BioSolveIT funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

BioSolveIT M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about BioSolveIT

What does BioSolveIT do?

BioSolveIT develops and licenses cheminformatics and molecular modeling software for computational drug discovery, centered on platforms such as SeeSAR (visual drug design dashboard), infiniSee (Chemical Space navigation platform), infiniSee xREAL (Enamine catalog access), HPSee (high-performance computing workflow environment), and Chemical Space Docking. The company also provides contract research services and command-line components (HYDE, FlexX, FTrees, SpaceLight, SpaceMACS, CoLibri) enabling pharmaceutical and academic researchers to screen billions to trillions of synthetically accessible compounds via combinatorial Chemical Space technology, with results directly orderable through partner compound suppliers.

Is BioSolveIT a public or private company?

BioSolveIT is a private company. It is classified as founder individual operated bootstrapped and is currently operating.

When was BioSolveIT founded?

BioSolveIT was founded in 2001. It employs 11 to 50 people.

Where is BioSolveIT based?

BioSolveIT is headquartered in Sankt Augustin, Germany, in the Europe region.

How does BioSolveIT make money?

Three revenue lines are on record. Software Licenses (Perpetual/Subscription) is the primary driver. The others are contract Research Services and compound Ordering (Partner Revenue Share).

Who are BioSolveIT's main competitors?

Direct peers on record are Cresset, Schrödinger, ChemAxon, Optibrium, Chemical Computing Group (CCG) and OpenEye Scientific (Cadence Design Systems). Emerging players are MolPort and XtalPi. Broad incumbents are BIOVIA (Dassault Systèmes) and Dotmatics.

Does BioSolveIT have an API?

No public API is recorded for BioSolveIT.

What industry is BioSolveIT in?

BioSolveIT's product category is Computational Drug Discovery Software. Its primary akta.pro industry code is HLAGAJAE, Cheminformatics & Molecular Modeling / CADD, with a secondary code of HLAGAJAO, AI/ML Platforms for Drug Discovery & Experiment Optimization. Its NAICS code is 541714 and its SIC code is 8731.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
NatureMerck: Innovation powered by digital and dataThis sponsored feature article describes Merck's digital and data innovation strategy across its healthcare, life science, and electronics sectors, detailing platforms including AIDDISON for AI-powered drug discovery, BayBE for AI-assisted experimental planning, SYNTHIA retrosynthesis software, Syntropy for healthcare data collaboration, and Athinia for semiconductor industry data sharing. The article highlights how Merck leverages AI, machine learning, and data ecosystems to accelerate drug discovery and optimize manufacturing across its business units, referencing strategic partnerships with companies like BioSolveIT, Cresset, and Palantir. Merck reports that BayBE powers approximately 30 internal use cases and notes market research projecting AI could generate over US$70 billion in drug discovery savings by 2028, though no fully AI-generated drug has yet been approved.PR NewswireCHEMriya - Billions of Molecules for R&D: OTAVA and BioSolveIT Team UpOTAVA and BioSolveIT announced the release of CHEMriya, a new pool of 11 billion tangible screening compounds designed for therapeutic R&D. This partnership combines OTAVA's on-demand chemical synthesis capabilities with BioSolveIT's infiniSee virtual screening platform to accelerate drug discovery. The initiative aims to reduce costs and increase productivity by allowing researchers to select specific molecules from a vast chemical space rather than synthesizing millions blindly.PR Newswire APACWuXi AppTec Research Service Division and BioSolveIT Introduce GalaXi®, a Vast New Chemical Space of Tangible MoleculesWuXi AppTec and BioSolveIT launched GalaXi, a virtual chemical space of billions of drug-like molecules. The space is built from WuXi AppTec's library and can be synthesized on demand, with turn-around times and costs reduced. A launch event is scheduled for October 10 in Cambridge, Massachusetts.PR NewswireWuXi AppTec Research Service Division and BioSolveIT Introduce GalaXi®, a Vast New Chemical Space of Tangible MoleculesWuXi AppTec Research Service Division and BioSolveIT jointly launched GalaXi®, a virtual chemical space offering access to billions of synthesizable drug-like compounds for drug discovery. The platform combines WuXi AppTec's novel scaffold library and chemistry expertise with BioSolveIT's software technology, enabling searches of billions of molecules within minutes and synthesis within weeks. This advancement addresses limitations of traditional virtual screening methods, which struggle beyond hundreds of millions of molecules, potentially accelerating the discovery of treatments for cancer, infections, and central nervous system diseases.GlobeNewswireZealand and BioSolveIT create unique software tool, adding new dimensions to peptide drug design and developmentZealand and BioSolveIT launched PepSee, a software tool combining Zealand's peptide design expertise with BioSolveIT's chemical informatics. The first version is available, with a second version expected within 18 months. BioSolveIT will own the software, while Zealand gets a free user license.